期刊文献+

1例妊娠期亚临床甲状腺功能减退合并贫血、痔疮患者的药学监护 被引量:7

Pharmaceutical Care for One Case of Subclinical Hypothyroidism Complicated with Anemia and Haemorrhoids during Pregnancy
下载PDF
导出
摘要 目的:探讨对妊娠期亚临床甲状腺功能减退合并贫血、痔疮患者的治疗方案及药学监护思路。方法:通过1例妊娠期亚临床甲减合并贫血、痔疮患者的药物治疗过程进行药学监护,并总结分析。结果:临床药师对患者的妊娠期亚临床甲减、贫血、痔疮治疗过程进行监护,并对期间口服补铁治疗贫血效果不佳时进行分析、探讨,提出合理建议。结论:妊娠期亚临床甲减患者合并贫血、痔疮等,在补充铁剂、小麦纤维素颗粒等药物治疗时,必须注意药物的相互作用,左甲状腺素钠应与铁剂和小麦纤维素颗粒错开至少2h时之上服用。因甲减致铁吸收障碍,当口服补充铁剂效果不佳时可考虑静脉铁剂治疗。 Objective : To discuss the effective therapeutic regimen and the thoughts of pharmaceutical care for subclinical hypothyroidism complicated with anemia and hemorrhoids during pregnancy. Methods: During the drug treatment process, clinical pharmacist provided pharmaceutical care for the patient, and the results were summarized and analyzed. Results: Clinical pharmacist performed pharmaceutical care for the treatment process of hypothyroidism, anemia and hemorrhoids during pregnancy, and when the oral iron treatment of hemorrhoids was with poor efficacy, clinical pharmacist analyzed and discussed the reasons and put forward reasonable suggestions. Conclusion: Subclinical hypothyroidism complicated with anemia and hemorrhoids during pregnancy treated with iron agent and wheat cellulose particles must pay attention to the drug interactions. The administration time of levothyroxine sodium and that of iron preparations and wheat cellulose particles should be staggered at least 2 hours. Because hypothyroidism can cause iron malabsorption, intravenous iron therapy may be considered when oral iron supplementation shows poor effect.
作者 汪凤梅 Wang Fengmei(Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, China)
出处 《中国药师》 CAS 2017年第9期1607-1609,共3页 China Pharmacist
基金 浙江省计划生育委员会资助项目(编号:JSW2013-A010)
关键词 妊娠期亚临床甲状腺功能减退 左甲状腺素钠 药物相互作用 Subclinical hypothyroidism Levothyroxine sodium Drug interactions
  • 相关文献

参考文献1

二级参考文献13

  • 1[1]Mancano MA. Drug interactions with levothyroxine[J]. Pharm Times, 2000,5(3):24.
  • 2[2]Harmon SM, Seifert CF. Levothyroxine-cholestyramine interaction reemphasized[J]. Ann Intern Med,1991,115(8):658.
  • 3[3]Rosenberg R. Malabsorption of thyroid hormone with cholestyramine administration[J]. Conn Med,1994,58(2):109.
  • 4[4]Sherman SI,Tielens ET,Ladenson PW. Sucralfate causes malabsorption of L-thyroxine[J]. Am J Med,1994,96(6):531.
  • 5[5]Mersebach H, Rasmussen AK, Kirkegaard L, et al. Intestinal adsorption of levothyroxine by antacids and laxatives: case stories and in vitro experiments[J]. Pharmacol Toxicol,1999,84(3):107.
  • 6[6]Liel Y, Sperber AD, Shany S. Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide[J]. Am J Med,1994,97(4):363.
  • 7[7]Sperber AD, Liel Y. Evidence for interference with the intestinal absorption of levothyroxine sodium by aluminum hydroxide[J]. Arch Intern Med,1992,152(1):183.
  • 8[8]Shakir KM, Chute JP, Aprill BS, et al. Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidism[J]. South Med J,1997,90(6):637.
  • 9[9]Shakir KM, Turton D, Aprill BS, et al. Anemia: a cause of intolerance to thyroxine sodium[J]. Mayo Clin Proc,2000,75(2):189.
  • 10[10]Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine[J]. JAMA,2000,283(21):2822.

共引文献7

同被引文献54

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部